(Q44003311)

English

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers.

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: efficacy of therapy and value of serum tumor markers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Wolfgang Stremmel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Henning Schulze-Bergkamen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Ivan Zuna

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Andreas Teufel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jochen Rudi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

43-53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12025890%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

https://scigraph.springernature.com/pub.10.1385/mo:19:1:43

0 references

The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of the modified regimen of etoposide, leucovorin and 5-fluorouracil for patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II Study of the Etoposide, Leucovorin and Fluorouracil Combination for Patients with Advanced Gastric Cancer Unsuitable for Aggressive Chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of advanced gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in the treatment of gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of carcinoma of the stomach

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 1990.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Grou

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiological research in stomach cancer: progress over the last ten years

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12025890

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44003311&oldid=2105556066"